These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9455499)

  • 1. Reactivity of twenty-two cytotoxic human monoclonal HLA antibodies towards soluble HLA class I in an enzyme-linked immunosorbent assay (PRA-STAT).
    Mulder A; Kardol M; Regan J; Buelow R; Claas F
    Hum Immunol; 1997; 56(1-2):106-13. PubMed ID: 9455499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-antibody testing: the immune phagocytosis inhibition test is superior to the PRA-STAT and NIH lymphocytotoxic test with respect to specificity.
    Flesch BK; Philipp M; Cassens U; Neppert J
    J Clin Lab Anal; 2001; 15(6):334-41. PubMed ID: 11793435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection.
    Kerman RH; Susskind B; Buelow R; Regan J; Pouletty P; Williams J; Gerolami K; Kerman DH; Katz SM; Van Buren CT; Kahan BD
    Transplantation; 1996 Jul; 62(2):201-5. PubMed ID: 8755816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
    Schönemann C; Groth J; Leverenz S; May G
    Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of HLA IgG antibodies by two enzyme-linked immunoassays, solubilized HLA class I and PRA-STAT. Comparison with the AHG PRA.
    Bryan CF; Baier KA; Flora-Ginter G; Shield CF; Warady BA; Aeder MI; Borkon AM; Estep TH; Forster J; Landreneau MD
    Transplantation; 1995 Dec; 60(12):1588-94. PubMed ID: 8545895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome.
    Worthington JE; Thomas AA; Dyer PA; Martin S
    Transplantation; 1998 Jan; 65(1):121-5. PubMed ID: 9448156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study.
    Buelow R; Mercier I; Glanville L; Regan J; Ellingson L; Janda G; Claas F; Colombe B; Gelder F; Grosse-Wilde H
    Hum Immunol; 1995 Sep; 44(1):1-11. PubMed ID: 8522449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of HLA antibodies with the PRA-STAT test. An ELISA test using soluble HLA class I molecules.
    Zachary AA; Griffin J; Lucas DP; Hart JM; Leffell MS
    Transplantation; 1995 Dec; 60(12):1600-6. PubMed ID: 8545897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients.
    Harmer AW; Heads AJ; Vaughn RW
    Transplantation; 1997 Jun; 63(12):1828-32. PubMed ID: 9210512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HLA antibodies interfere in the detection of soluble HLA class I molecules.
    Koelman CA; Ensink W; Mulder A; Tanke J; Doxiadis II; Claas FH
    Hum Immunol; 1999 May; 60(5):414-23. PubMed ID: 10447400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of enzyme-linked immunosorbent assay-detected IgG anti-HLA antibodies for pediatric renal allograft rejection.
    Dalla Vecchia LK; Book BK; Milgrom ML; Jindal RM; Leapman SB; Filo RS; Pescovitz MD
    Transplantation; 1997 Dec; 64(12):1744-7. PubMed ID: 9422414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies.
    Regan J; Monteiro F; Speiser D; Kalil J; Pouletty P; Buelow R
    Am J Kidney Dis; 1996 Jul; 28(1):92-8. PubMed ID: 8712228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of enzyme-linked immunoabsorbent assays and flow cytometry techniques for the detection of HLA specific antibodies.
    Worthington JE; Robson AJ; Sheldon S; Langton A; Martin S
    Hum Immunol; 2001 Oct; 62(10):1178-84. PubMed ID: 11600227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation.
    Christiaans MH; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 2000 Mar; 69(5):917-27. PubMed ID: 10755551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typing of a panel of soluble HLA class I antigens by enzyme-linked immunosorbent assay.
    Pouletty C; Mercier I; Glanville L; Tomavo N; Igoudin L; Pouletty P; Buelow R
    Hum Immunol; 1994 Jul; 40(3):218-27. PubMed ID: 7960966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.